{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:47:23Z","timestamp":1773172043400,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.mycmed.2026.101601","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:51:37Z","timestamp":1767804697000},"page":"101601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro Susceptibilities to caspofungin of Candida spp. isolated from the Polyvalent Intensive Care Unit of Fattouma Bourguiba University Hospital: First report of resistant mutants in Tunisia"],"prefix":"10.1016","volume":"36","author":[{"given":"Sameh","family":"Belgacem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7041-6373","authenticated-orcid":false,"given":"Wissal","family":"Chebil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichrak","family":"Ferjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donia","family":"Ghedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Mastouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamouda","family":"Babba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2026.101601_bib0001","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101601_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02299-17","article-title":"FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility","volume":"62","author":"Suwunnakorn","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2026.101601_bib0003","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ijid.2020.01.037","article-title":"Evaluation of first-line therapies for the treatment of candidemia in ICU patients: a propensity score analysis","volume":"93","author":"Bienvenu","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.mycmed.2026.101601_bib0004","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-021-01640-7","article-title":"Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?","volume":"49","author":"Soulountsi","year":"2021","journal-title":"Infection"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101601_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-019-01115-0","article-title":"Choosing the right antifungal agent in ICU patients","volume":"36","author":"Chatelon","year":"2019","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101601_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2015.09.041","article-title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","volume":"72","author":"Bailly","year":"2016","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101601_bib0007","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/jam.14949","article-title":"Biofilm of Candida albicans: formation, regulation and resistance","volume":"131","author":"Pereira","year":"2021","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.mycmed.2026.101601_bib0008","series-title":"Early implementation protocol for inclusion of candida spp","year":"2019"},{"key":"10.1016\/j.mycmed.2026.101601_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ814","article-title":"Echinocandins: the expanding antifungal armamentarium","volume":"61","author":"Aguilar-Zapata","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101601_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2026.101601_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.02573","article-title":"Fungal cell wall: emerging antifungals and drug resistance","volume":"10","author":"Lima","year":"2019","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101601_bib0012","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1007\/s00134-018-5363-x","article-title":"What\u2019s new on emerging resistant Candida species","volume":"45","author":"Cortegiani","year":"2019","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101601_bib0013","article-title":"Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?","volume":"33","author":"Fekkar","year":"2014","journal-title":"Eur J Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2026.101601_bib0014","unstructured":"Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3 and Supplement S. Wayne, PA. 2008;3:6\u201312."},{"key":"10.1016\/j.mycmed.2026.101601_bib0015","series-title":"Performance standards for antifungal susceptibility testing of yeasts","year":"2022"},{"key":"10.1016\/j.mycmed.2026.101601_bib0016","unstructured":"WHO. Collaborating Center for Drug Statistics Methodology; 2025. www.whocc.no."},{"issue":"11","key":"10.1016\/j.mycmed.2026.101601_bib0017","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive candidiasis in critical care: challenges and future directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mycmed.2026.101601_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpubh.2021.779590","article-title":"Candida isolates from blood and other normally sterile foci from ICU patients: determination of epidemiology, antifungal susceptibility profile and evaluation of associated risk factors","volume":"9","author":"Wang","year":"2021","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101601_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.idc.2017.05.005","article-title":"Invasive fungal infections in the intensive care unit","volume":"31","author":"Ostrosky-Zeichner","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.mycmed.2026.101601_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13148","article-title":"Breakthrough invasive fungal infections: who is at risk?","volume":"63","author":"Jenks","year":"2020","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101601_bib0021","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1007\/s00253-020-11022-y","article-title":"Echinocandins: structural diversity, biosynthesis, and development of antimycotics","volume":"105","author":"H\u00fcttel","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101601_bib0022","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.mycmed.2016.04.055","article-title":"Sensibilit\u00e9 de levures aux antifongiques : evaluation des souches isol\u00e9es de pr\u00e9l\u00e8vements profonds","volume":"26","author":"Dhraief","year":"2016","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2026.101601_bib0023","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the sentry antifungal surveillance program: results for Candida species from 1997 to 2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101601_bib0024","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-017-4731-2","article-title":"Intensive care medicine research agenda on invasive fungal infection in critically ill patients","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"issue":"Suppl. 6","key":"10.1016\/j.mycmed.2026.101601_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101601_bib0026","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-014-3404-7","article-title":"Resistance of Candida spp. To antifungal drugs in the ICU: where are we now?","volume":"40","author":"Maubon","year":"2014","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101601_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210397","article-title":"Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing","volume":"14","author":"Spettel","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101601_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.idc.2021.03.004","article-title":"Antifungal susceptibility testing and identification","volume":"35","author":"Kidd","year":"2021","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.mycmed.2026.101601_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal susceptibility testing: current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.mycmed.2026.101601_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. To anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.mycmed.2026.101601_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior Echinocandin exposure","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101601_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00783-20","article-title":"genetic basis of azole and echinocandin resistance in clinical Candida glabrata in Japan","volume":"64","author":"Khalifa","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101601_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mycmed.2026.101601_bib0034","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1R020","article-title":"Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches","volume":"46","author":"Beyda","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.mycmed.2026.101601_bib0035","series-title":"\u00c9tude de la sensibilit\u00e9 aux \u00e9chinocandines de Candida spp. chez des transplant\u00e9s h\u00e9patiques \u00e0 l'h\u00f4pital Henri Mondor","author":"Prigent","year":"2016"},{"issue":"2","key":"10.1016\/j.mycmed.2026.101601_bib0036","article-title":"Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: fifteen years of interpretation and assessment","volume":"58","author":"Fraser","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2026.101601_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.02038","article-title":"Fluconazole and echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a french cohort of patients harboring low rates of resistance","volume":"7","author":"Delli\u00e8re","year":"2016","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.mycmed.2026.101601_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based Candidemia surveillance program, 2008\u20132014","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101601_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00836-10","article-title":"FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance","volume":"54","author":"Zimbeck","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101601_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.mycmed.2026.101601_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00782-14","article-title":"Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4290 clinical isolates of candida by using CLSI methods and interpretive criteria","volume":"52","author":"Pfaller","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101601_bib0042","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mycmed.2026.101601_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00195-18","article-title":"Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in the DNA mismatch repair pathway","volume":"62","author":"Singh","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.mycmed.2026.101601_bib0044","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000617.v4","article-title":"Inter-laboratory variability of caspofungin MICs for Nakaseomyces glabrata isolates - an Irish tertiary hospital experience","volume":"5","author":"Ali","year":"2023","journal-title":"Access Microbiol"},{"issue":"8","key":"10.1016\/j.mycmed.2026.101601_bib0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.mycmed.2026.101601_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cutoff values and whole-genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mycmed.2026.101601_bib0047","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01711-09","article-title":"Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains","volume":"54","author":"Castanheira","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mycmed.2026.101601_bib0048","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"issue":"23","key":"10.1016\/j.mycmed.2026.101601_bib0049","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1016\/j.cub.2021.09.084","article-title":"Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata","volume":"31","author":"Ksiezopolska","year":"2021","journal-title":"Current Biology"},{"key":"10.1016\/j.mycmed.2026.101601_bib0050","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.mycmed.2026.101601_bib0051","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkr394","article-title":"Antifungal use influences Candida species distribution and susceptibility in the intensive care unit","volume":"66","author":"Fournier","year":"2011","journal-title":"J Antimicrob Chemother"}],"updated-by":[{"DOI":"10.1016\/j.mycmed.2026.101606","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523326000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523326000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:44:06Z","timestamp":1773107046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523326000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1156523326000028"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2026.101601","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro Susceptibilities to caspofungin of Candida spp. isolated from the Polyvalent Intensive Care Unit of Fattouma Bourguiba University Hospital: First report of resistant mutants in Tunisia","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2026.101601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SFMM. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101601"}}